21.01.2025 • News

Grupa Azoty Nears Sale of Polyolefins Business to Orlen

Grupa Azoty and Orlen have agreed to continue to work on the terms of a potential transaction whereby Orlen – or another entity designated by Orlen – would acquire all or a portion of the shares currently held by Grupa Azoty in Grupa Azoty Polyolefins or otherwise execute the investment.

The companies said that negotiations on the terms of the deal, as well as an analysis of the potential transaction including due diligence, are scheduled to be finalized by Mar. 31, 2025.

“Since December, based on the signed cooperation agreement and the earlier letter of intent, we have been working intensively on potential solutions for the future of Grupa Azoty Polyolefins. As a result, we can now unequivocally confirm our chosen direction, which is to sell all or part of Polyolefins’ shares held by Grupa Azoty. At this stage, we will begin due diligence and seek to negotiate the terms of a potential transaction,” said Adam Leszkiewicz, president of Grupa Azoty’s management board.

“At Grupa Azoty, we believe that this collaboration can bring mutual benefits. From our perspective, a potential transaction is one of the key elements of our ongoing Recovery Program, under which we are developing a new business model for the group,” Leszkiewicz added.

In September 2024, Orlen and Grupa Azoty announced their talks about a strategic analysis of potential transactions in the polymers segment.

© Pressmaster/Shutterstock
© Pressmaster/Shutterstock

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.